150 related articles for article (PubMed ID: 36822486)
1. A senolytic immunotoxin eliminates p16
Sugiyama Y; Harada T; Kamei Y; Yasuda T; Mashimo T; Nishikimi A; Maruyama M
Exp Gerontol; 2023 Apr; 174():112130. PubMed ID: 36822486
[TBL] [Abstract][Full Text] [Related]
2. Cellular Senescence in Diabetes Mellitus: Distinct Senotherapeutic Strategies for Adipose Tissue and Pancreatic β Cells.
Murakami T; Inagaki N; Kondoh H
Front Endocrinol (Lausanne); 2022; 13():869414. PubMed ID: 35432205
[TBL] [Abstract][Full Text] [Related]
3. Aging of mice is associated with p16(Ink4a)- and β-galactosidase-positive macrophage accumulation that can be induced in young mice by senescent cells.
Hall BM; Balan V; Gleiberman AS; Strom E; Krasnov P; Virtuoso LP; Rydkina E; Vujcic S; Balan K; Gitlin I; Leonova K; Polinsky A; Chernova OB; Gudkov AV
Aging (Albany NY); 2016 Jul; 8(7):1294-315. PubMed ID: 27391570
[TBL] [Abstract][Full Text] [Related]
4. Aryl hydrocarbon receptor blocks aging-induced senescence in the liver and fibroblast cells.
Nacarino-Palma A; Rico-Leo EM; Campisi J; Ramanathan A; González-Rico FJ; Rejano-Gordillo CM; Ordiales-Talavero A; Merino JM; Fernández-Salguero PM
Aging (Albany NY); 2022 May; 14(10):4281-4304. PubMed ID: 35619220
[TBL] [Abstract][Full Text] [Related]
5. Tumor suppressor and aging biomarker p16(INK4a) induces cellular senescence without the associated inflammatory secretory phenotype.
Coppé JP; Rodier F; Patil CK; Freund A; Desprez PY; Campisi J
J Biol Chem; 2011 Oct; 286(42):36396-403. PubMed ID: 21880712
[TBL] [Abstract][Full Text] [Related]
6. Cells exhibiting strong
Liu JY; Souroullas GP; Diekman BO; Krishnamurthy J; Hall BM; Sorrentino JA; Parker JS; Sessions GA; Gudkov AV; Sharpless NE
Proc Natl Acad Sci U S A; 2019 Feb; 116(7):2603-2611. PubMed ID: 30683717
[TBL] [Abstract][Full Text] [Related]
7. Immunosenescence profile and expression of the aging biomarker (p16
Bourlon MT; Velazquez HE; Hinojosa J; Orozco L; Rios-Corzo R; Lima G; Llorente L; Hernandez-Ramirez DF; Valentin-Cortez FJ; Medina-Rangel I; Atisha-Fregoso Y
BMC Cancer; 2020 Sep; 20(1):882. PubMed ID: 32928147
[TBL] [Abstract][Full Text] [Related]
8. Restored immune cell functions upon clearance of senescence in the irradiated splenic environment.
Palacio L; Goyer ML; Maggiorani D; Espinosa A; Villeneuve N; Bourbonnais S; Moquin-Beaudry G; Le O; Demaria M; Davalos AR; Decaluwe H; Beauséjour C
Aging Cell; 2019 Aug; 18(4):e12971. PubMed ID: 31148373
[TBL] [Abstract][Full Text] [Related]
9. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders.
Baker DJ; Wijshake T; Tchkonia T; LeBrasseur NK; Childs BG; van de Sluis B; Kirkland JL; van Deursen JM
Nature; 2011 Nov; 479(7372):232-6. PubMed ID: 22048312
[TBL] [Abstract][Full Text] [Related]
10. Tissue specificity of senescent cell accumulation during physiologic and accelerated aging of mice.
Yousefzadeh MJ; Zhao J; Bukata C; Wade EA; McGowan SJ; Angelini LA; Bank MP; Gurkar AU; McGuckian CA; Calubag MF; Kato JI; Burd CE; Robbins PD; Niedernhofer LJ
Aging Cell; 2020 Mar; 19(3):e13094. PubMed ID: 31981461
[TBL] [Abstract][Full Text] [Related]
11. p16
Novais EJ; Diekman BO; Shapiro IM; Risbud MV
Matrix Biol; 2019 Sep; 82():54-70. PubMed ID: 30811968
[TBL] [Abstract][Full Text] [Related]
12. Two mechanisms underlying the loss of p16(Ink4a) function are associated with distinct tumorigenic consequences for WS MEFs escaping from senescence.
Wu X; Jia S; Zhang X; Si X; Tang W; Luo Y
Mech Ageing Dev; 2012 Aug; 133(8):549-55. PubMed ID: 22813853
[TBL] [Abstract][Full Text] [Related]
13. The effect of Yang Yan Qing E Wan on senescent phenotypes and the expression of β-catenin and p16
Tian LM; Peng Y; Ke D; Li H; Chen L; Zhang C; Sen L; Tian DZ; Zhou MS; Ai XS; Wang P
J Tissue Viability; 2020 Nov; 29(4):354-358. PubMed ID: 32768331
[TBL] [Abstract][Full Text] [Related]
14. Expression of p16(INK4a) prevents cancer and promotes aging in lymphocytes.
Liu Y; Johnson SM; Fedoriw Y; Rogers AB; Yuan H; Krishnamurthy J; Sharpless NE
Blood; 2011 Mar; 117(12):3257-67. PubMed ID: 21245485
[TBL] [Abstract][Full Text] [Related]
15. Murine mesenchymal cells that express elevated levels of the CDK inhibitor p16(Ink4a) in vivo are not necessarily senescent.
Frescas D; Hall BM; Strom E; Virtuoso LP; Gupta M; Gleiberman AS; Rydkina E; Balan V; Vujcic S; Chernova OB; Gudkov AV
Cell Cycle; 2017 Aug; 16(16):1526-1533. PubMed ID: 28650766
[TBL] [Abstract][Full Text] [Related]
16. Increased p16
Sasaki M; Sato Y; Nakanuma Y
J Autoimmun; 2020 Feb; 107():102377. PubMed ID: 31812332
[TBL] [Abstract][Full Text] [Related]
17. Differential roles for cyclin-dependent kinase inhibitors p21 and p16 in the mechanisms of senescence and differentiation in human fibroblasts.
Stein GH; Drullinger LF; Soulard A; Dulić V
Mol Cell Biol; 1999 Mar; 19(3):2109-17. PubMed ID: 10022898
[TBL] [Abstract][Full Text] [Related]
18. Defined p16
Grosse L; Wagner N; Emelyanov A; Molina C; Lacas-Gervais S; Wagner KD; Bulavin DV
Cell Metab; 2020 Jul; 32(1):87-99.e6. PubMed ID: 32485135
[TBL] [Abstract][Full Text] [Related]
19. Survey of senescent cell markers with age in human tissues.
Idda ML; McClusky WG; Lodde V; Munk R; Abdelmohsen K; Rossi M; Gorospe M
Aging (Albany NY); 2020 Mar; 12(5):4052-4066. PubMed ID: 32160592
[TBL] [Abstract][Full Text] [Related]
20. Transgenic expression of the p16(INK4a) cyclin-dependent kinase inhibitor leads to enhanced apoptosis and differentiation arrest of CD4-CD8- immature thymocytes.
Lagresle C; Gardie B; Eyquem S; Fasseu M; Vieville JC; Pla M; Sigaux F; Bories JC
J Immunol; 2002 Mar; 168(5):2325-31. PubMed ID: 11859122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
